Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...-November-2017/Imaging-Diagnosis-and-Staging

Date: 22 Nov 2017
Presenter: K. Lang, SE
Resources: Presentation
Topics: Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...sia-2017-Congress/HPV-and-new-staging-system

Date: 19 Nov 2017
Presenter: Amanda Psyrri
Resources: Presentation, Webcast
Topics: Cancer Aetiology, Epidemiology, Prevention, Head and Neck Cancers, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...ty-assessment-The-same-for-all-interventions

Date: 19 Nov 2017
Presenter: Raquel Perez Lopez
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Drug Development, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...-on-Ultrasonographic-Pathologic-Features-57O

BackgroundAxillary lymph node status is an important prognostic factor of breast cancer patients. Several variables have been confirmed as predictors of axillary lymph node metastasis in breast cancer....

Date: 19 Nov 2017
Presenter: Jianguo Lai
Resources: Abstract, Presentation, Webcast
Topics: Breast Cancer, Early Stage, Breast Cancer, Imaging, Diagnosis and Staging, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...volume-with-the-subtype-of-breast-cancer-37P

BackgroundThe risk of relapse associated with each breast cancer molecular subtype was determined in a large cohort of patients with breast cancer. In this study, the association of mammographic breast...

Date: 18 Nov 2017
Presenter: Wei-Chung Shia
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...Lymph-Nodes-in-Early-stage-Breast-Cancer-65P

BackgroundThe AMAROS trial and the ACOSOG Z0011 trial showed that axillary lymph node dissection (ALND) could be spared in certain breast cancer patients with sentinel lymph node (SLN) metastasis on...

Date: 18 Nov 2017
Presenter: Yurina Maeshima
Resources: Abstract
Topics: Breast Cancer, Early Stage, Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...ving-neoadjuvant-therapy-from-2010-2016.-76P

BackgroundThere is no way of predicting who among our early breast cancer patients develop liver injury during neoadjuvant treatment. It is our aim to determine such event by determining Computed...

Date: 18 Nov 2017
Presenter: AMABELLE TRINA Gerona
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Early Stage, Complications of Treatment, Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...nts-Undergoing-Breast-Conserving-Surgery-79P

BackgroundThe aim of this study was to assess tissue computed tomography (CT) number changes and corresponding dosimetric shifts in repeatedly performed simulation CT (re-sim CT) scans after conventionally...

Date: 18 Nov 2017
Presenter: Dong Soo Lee
Resources: Abstract
Topics: Breast Cancer, Early Stage, Breast Cancer, Imaging, Diagnosis and Staging, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ancer-on-ring-type-dedicated-breast-PET-391P

BackgroundDedicated breast PET (DbPET) is a high-resolution molecular breast imaging method that detects subcentimeter breast cancers. However, it is unclear why some breast cancers are invisible to DbPET using 18F-fluorodeoxyglucose (FDG).

Date: 18 Nov 2017
Presenter: Shinsuke Sasada
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...-stage-non-small-cell-lung-cancer-NSCLC-401P

BackgroundInter-observer variability in contouring is a well-known phenomenon in radiotherapy. The purpose of the study was to evaluate the magnitude of interobserver variability in the delineation of...

Date: 18 Nov 2017
Presenter: Mangesh Patil
Resources: Abstract
Topics: Non-Small-Cell Lung Cancer, Early Stage, Imaging, Diagnosis and Staging